Jeffrey L. Ives, Director at Cara Therapeutics, Inc. (CARA), sold 16,360 shares at $16.04 ($262K) on 2021-11-12, disclosed to the SEC on 2021-11-16.
Open-market sale of $262k CARA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.04 | 8,180 | $131K | 50.0% |
| 2 | $16.04 | 8,180 | $131K | 50.0% |
| Total | $16.04 avg | 16,360 | $262K | 100% |
| Filing → |
| CARA | SELL | 2021-06-07 | $33K | — | Filing → |
| CARA | SELL | 2020-11-24 | $39K | — | Filing → |
| CARA | SELL | 2020-06-03 | $16K | — | Filing → |